Coinbase Global Inc. (COIN)

Coinbase's stock has fallen hard into the lower end of its yearly range, and the most recent move came after a quarter that missed expectations badly. The price of $132.13 sits just 2.10% above its 52-week low of $129.41, and it is 57.58% below the 52-week high of $311.50. Analysts still lean toward Buy, but CleaRank's own score is weak, and the gap between Wall Street's view and the trend is the central question for anyone following the shares. The stock fell 10.59% in the first session after the July 30, 2026 report, when adjusted earnings of -$1.36 per share came in far below the -$0.23 estimate. Over the past year the shares are down 58.44%.

Adjusted EPS of -$1.36 missed the -$0.23 estimate by 491.30%, and the stock fell 10.59% in the next session. The February 12, 2026 report was also a miss, at -$2.49 against $0.94 expected, though the shares rose 16.46% that day. Three of the six reports beat estimates, and two of those beats were followed by a lower share price, so a beat has not reliably lifted the stock.

Analysts expect revenue to shrink 27.9% this year to $5.2B. The company is also reporting a net loss, with a net profit margin of -12.89% and a return on equity of -4.68%, against a sector median return on equity of 13.8%. Its debt-to-equity ratio of 0.49 is a less pressing concern than the shrinking top line.

Insiders sold $853.4M of stock over the last 18 months across 86 sales, and made no open-market purchases. Such sales are often planned in advance or made to cover tax on vesting shares, so they say less than purchases would. On the analyst side, 23 of 38 analysts rate the stock Buy or Strong Buy, 12 Hold and 3 Sell. The median target of $199.00 is 50.6% above the price, yet that is a forecast, and the shares have fallen 33.60% below the past year.

The base case is that COIN stays under pressure while it trades below its 20-day EMA, 50-day SMA and 200-day SMA, and that it needs a sustained rise through $153.60 before the trend can be called repaired. Analysts' figures point to a higher level: the median 12-month target is $199.00, with a range from $110.00 to $280.00 across the analysts covering it. Those targets rest on expectations that the company returns to growth. The analysts expect 2026 EPS of -$0.34 and 2027 EPS of $2.47, and expect 2026 revenue to shrink 27.9% to $5.2B. What would make the picture better is a revenue turn that matches the sector, a return to positive EPS, or a clear rise in the price above the 50-day SMA at $173.38. What would make it worse is a close below the 52-week low of $129.41, which would mark a new low for the range, or further weak results. The stock's beta of 3.35 and a typical daily move of 4.06% mean that large swings in either direction are normal for it.

Support: the 52-week low at $129.41 is the nearest level below the price and marks the bottom of the range. A break below it would open a new low for the year, with no support level between the price and that low. Resistance: the 20-day EMA at $153.60 is the nearest level above the price. A move through it would be the first sign that short-term selling is easing. The 50-day SMA at $173.38 comes next and is the level the trend has to recover to change the reading against the medium term. The 200-day SMA at $175.18 sits just above it, so these two averages form a single zone. The 52-week high at $311.50 is far above the current price and marks the top of the range.